Clinical trial
Long-term Study of Ciclosporin for Atopic Dermatitis
NCT00232063 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00232063 |
|---|---|
| Title | Long-term Study of Ciclosporin for Atopic Dermatitis |
| Official title | Long-term Study of Ciclosporin for Atopic Dermatitis |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Severe Atopic Dermatitis |
| Intervention type | Drug |
| Interventions | ciclosporin |
| Start date | May 1, 2004 |
| Primary completion | Nov 1, 2005 |
| First posted | Oct 4, 2005 |
| Last update posted | Nov 2, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: